Cargando…
Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of lymphoma, with different clinical manifestation and prognosis. The International Prognostic Index (IPI), an index designed during the prerituximab era for aggressive lymphoma, showed variable values in the prediction of patient clinic...
Autores principales: | Shi, Qing, Shen, Rong, Wang, Chao-Fu, Fan, Xing, Qian, Ying, Ou-Yang, Bin-Shen, Zhao, Yan, Leboeuf, Christophe, Janin, Anne, Cheng, Shu, Wang, Li, Zhao, Wei-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646333/ https://www.ncbi.nlm.nih.gov/pubmed/29109622 http://dx.doi.org/10.1155/2017/7960907 |
Ejemplares similares
-
HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy
por: Wan, Xin, et al.
Publicado: (2023) -
CD5 and CD43 Expression are Associate with Poor Prognosis in DLBCL Patients
por: Huang, Hui, et al.
Publicado: (2018) -
IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL
por: Li, Han-Bing, et al.
Publicado: (2023) -
A novel NET-related gene signature for predicting DLBCL prognosis
por: Shi, Huizhong, et al.
Publicado: (2023) -
High pretreatment plasma D-dimer levels predict poor prognosis in gastrointestinal cancers: A meta-analysis
por: Rong, Guoyi, et al.
Publicado: (2019)